Read + Share
Amedeo Smart
Independent Medical Education
Cree BA, Bennett JL, Kim HJ, Weinshenker BG, et al. Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD. Mult Scler 2021;27:2052-2061.PMID: 33538237
Email
LinkedIn
Facebook
Twitter
Privacy Policy